Top 5 Extreme Value Stocks To Buy

Page 5 of 5

1. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Number of Hedge Fund Holders: 25

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), initially called Microbia, Inc., is a pharmaceutical company that is focused on human therapeutics and gastrointestinal products. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has operations in the U.S. and Switzerland and has two brands, Linzess and Constella.

Two Wall Street analysts have covered Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) stock over the last three months with an average price target of $21, and both maintain a Buy rating on the company stock.

In Q2, the number of hedge funds with a stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) grew to 25 from 20 in the previous quarter. The most prominent shareholder of the company was Alex Denner’s Sarissa Capital Management with 16.39 million shares worth nearly $174.39 million, making up 17.36% of the fund’s portfolio.

Follow Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

You can also look at the 10 Fastest Growing Regions in the World and the 17 Largest Media Companies in the World in 2023.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5